News
09 December 2015

The 2016 World Cancer Congress has reached 600 registrations in two months

Boost your skills and learn from the best at the 2016 World Cancer Congress for only €300 instead of €620

600 cancer and health professionals from around the world have secured their attendance at the Paris Congress so far. As individuals or groups, they have already maximised the value of their participation, taking advantage of the exclusive Autumn Festival Registration Offer at €300 which runs until 15 January 2016.

“At FEMAMA Brazil, we have decided to make the most of this appealing offer! We will send a delegation to Paris and we will host an exhibition space in the Latin American Corner of the Global Village.

“FEMAMA, as a national patient support organisation, will not only gain a great international exposure – we, as a team, will also be exposed to an innovative educational programme which should comprise more than 120 multidisciplinary sessions, workshops, panel discussions and debates. We look forward to meeting and exchanging with high calibre speakers and attendees throughout the week, including at official celebrations such as the Welcome Reception, the Opening Ceremony and the Closing Reception - to name a few,” said Maira Caleffi, Founder and President, FEMAMA, and UICC Board Member

If you are looking for a more bespoke approach and a broader engagement, please consult our sponsorship & exhibition brochure or contact Mrs Marion Gilodi at Gilodi@uicc.org.

Last update

Friday 07 June 2019

Share this page

Related content

Several people at an event in discussion, focus on a woman wearing a headscarf

The preliminary programme for the World Cancer Congress 2026 is now available, highlighting high‑level sessions curated by an Expert Programme Committee and aligned with the Congress themes. Abstract submissions, registration at the lowest rate and partnership opportunities remain open.

Two women and a man in suit receiving an award on stage

Researchers and professionals are invited to submit by 1 April 2026 abstracts that address key challenges in cancer prevention, treatment, and care, with the potential to attract media interest and a chance to shape global cancer control.